Kyle Amber to Time Factors
This is a "connection" page, showing publications Kyle Amber has written about Time Factors.
Connection Strength
0.125
-
Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Am J Clin Dermatol. 2016 Feb; 17(1):71-7.
Score: 0.098
-
Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center. J Am Acad Dermatol. 2018 04; 78(4):806-808.
Score: 0.028